LI:EURONEXT PARISKlepierre SA Analysis
Data as of 2026-07-16 - not real-time
$12.73
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Li Auto (LI) is trading at $12.73, well below its 20‑day ($12.40), 50‑day ($14.69) and 200‑day ($17.74) moving averages, indicating a bearish technical backdrop. The stock sits just above the computed support level of $11.65 and faces resistance near $14.21, while the RSI of 45 suggests neither overbought nor oversold conditions. Despite the bearish trend, the MACD histogram has turned positive, hinting at emerging short‑term bullish momentum. Valuation metrics are compelling: a forward P/E of 12.38, a price‑to‑sales ratio of 0.12 and a P/B of 1.25 place the shares deep in value territory, with analysts forecasting a 44% upside to a median target of $18.02. The company’s cash pile of $93.1 bn dwarfs its $17.7 bn debt, giving it a comfortable liquidity cushion despite negative operating cash flow. Recent material news – the launch of the all‑new Li L8 and a quarterly delivery of 95,142 vehicles generating RMB 23 bn in revenue – provides a tangible catalyst that could accelerate the turnaround hinted at by a forward EPS of $1.03 versus a trailing loss of $0.27. Overall, the blend of strong balance‑sheet strength, attractive valuation and positive product news offsets the current earnings weakness and high near‑term volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Positive MACD histogram indicating short‑term momentum
- Immediate sales boost from the new Li L8 launch
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation multiples (forward P/E ~12, P/S ~0.12)
- Forward earnings estimate turning positive
- Strong cash position mitigating execution risk
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Long‑term growth of China's EV market
- Continued need to convert revenue growth into profitability
- Balance‑sheet strength versus lingering negative cash flows
Key Metrics & Analysis
Financial Health
Revenue Growth-11.40%
Profit Margin-1.66%
P/E Ratio12.4
ROE-2.50%
ROA-1.51%
Debt/Equity25.12
P/B Ratio1.2
Op. Cash Flow$-13001422848
Free Cash Flow$-15601390592
Technical Analysis
TrendBearish
RSI45.3
Support$11.65
Resistance$14.21
MA 20$12.40
MA 50$14.69
MA 200$17.74
MACDBullish
VolumeStable
Fear & Greed Index93.14
Valuation
Target Price$18.31
Upside/Downside43.86%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.92
Volatility40.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.